India reports 7,284 new cases and 190 new deaths.
I really, really, really and truthfully hope you can re-post this in November ...
I'd wait until Thursday ... there is so much "cleaning up" that nothing is even close to certain as far as current numbers go, right now ... hell, our local health official said today he suspects based on testing data that 13,000 --- Yes, 13,000 unreported and undocumented in this County have had it but showed no symptoms ... take that for what it's worth ... one way or another ...I was a bit concerned we’d see a huge spike in deaths reported nationally today after the holiday weekend backlog, but it looks like we’re going to come in relatively low. Over 1,000, but lower than any weekday (besides Mondays) in awhile. I guess I should wait for the final numbers come out in a few minutes, though.
79 new cases in South Korea. This is not good.
I noticed our favorite IHME model updated again and downgraded NC to just 1,400 deaths now, down from 2,400 last week and over 4,000 earlier this month. So, who knows...
Dr Harvey Risch is Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.
Hydroxychloroquine+azithromycin has been widely misrepresented in both clinical reports and public media, and outpatient trials results are not expected until September. Early outpatient illness is very different than later hospitalized florid disease and the treatments differ. Evidence about use of hydroxychloroquine alone, or of hydroxychloroquine+azithromycin in inpatients, is irrelevant concerning efficacy of the pair in early high-risk outpatient disease. Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy.
These medications need to be widely available and promoted immediately for physicians to prescribe.